Stay updated with breaking news from Argenx se. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
VYVGART® now approved in Japan for both generalized myasthenia gravis and primary immune thrombocytopenia (ITP) Regulatory decision in Japan represents. ....
Actively managed mutual funds make sense when investing in healthcare, since companies’ future prospects are often difficult for the market to price. ....
The sector offers a safe haven from macroeconomic and earnings concerns ahead of quarterly results from European companies, according to the Wall Street bank. ....
Argenx stock lost a third of its value as the Amsterdam biotech said a late-stage trial did not meet primary or secondary endpoints. The Phase 3 study was of. ....